These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 849377)

  • 1. The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia.
    Moutafis CD; Simons LA; Myant NB; Adams PW; Wynn V
    Atherosclerosis; 1977 Mar; 26(3):329-34. PubMed ID: 849377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia.
    Miettinen TA; Lempinen M
    Eur J Clin Invest; 1977 Dec; 7(6):509-14. PubMed ID: 204491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
    Miettinen TA
    J Clin Invest; 1979 Nov; 64(5):1485-93. PubMed ID: 387820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary retrograded starch on the metabolism of neutral steroids and bile acids in rats.
    Verbeek MJ; De Deckere EA; Tijburg LB; Van Amelsvoort JM; Beynen AC
    Br J Nutr; 1995 Dec; 74(6):807-20. PubMed ID: 8562568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.
    Moutafis CD; Myant NB
    Clin Sci; 1969 Oct; 37(2):443-54. PubMed ID: 5359001
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in cholesterol metabolism with dietary cholesterol in children with familial hypercholesterolaemia.
    Martin GM; Nestel P
    Clin Sci (Lond); 1979 Apr; 56(4):377-80. PubMed ID: 477222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient.
    Moore RB; Crane CA; Frantz ID
    J Clin Invest; 1968 Jul; 47(7):1664-71. PubMed ID: 5658594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestyramine treatment during pregnancy in the rat results in hypercholesterolemia.
    Hassan AS; Hackley JJ; Johnson LL
    Atherosclerosis; 1985 Nov; 57(2-3):139-48. PubMed ID: 4084352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters.
    Trautwein EA; Forgbert K; Rieckhoff D; Erbersdobler HF
    Biochim Biophys Acta; 1999 Jan; 1437(1):1-12. PubMed ID: 9931405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and bile acid synthesis in two families with homozygous and heterozygous hypercholesterolemia.
    Miettinen TA
    Arteriosclerosis; 1984; 4(4):383-8. PubMed ID: 6466195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
    Grundy SM; Ahrens EH; Salen G
    J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease.
    Miettinen TA
    Gut; 1972 Sep; 13(9):682-9. PubMed ID: 4118161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.
    Spengel FA; Jadhav A; Duffield RG; Wood CB; Thompson GR
    Lancet; 1981 Oct; 2(8250):768-70. PubMed ID: 6116902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind trial of cholestyramine in post-vagotomy diarrhoea.
    Duncombe VM; Bolin TD; Davis AE
    Gut; 1977 Jul; 18(7):531-5. PubMed ID: 326641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypercholesterolemia by interference with bile acid metabolism.
    Grundy SM
    Arch Intern Med; 1972 Oct; 130(4):638-48. PubMed ID: 4562153
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia.
    Nazir DJ; Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1972 Jul; 46(1):95-102. PubMed ID: 5039828
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
    Angelin B; Eriksson M; Einarsson K
    Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in bile acid excretion in subjects with hypercholesterolaemia, hypertriglyceridaemia and overweight.
    Nestel PJ; Hunter JD
    Aust N Z J Med; 1974 Oct; 4(5):491-6. PubMed ID: 4532917
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
    Nikkila EA; Miettinen TA; Lanner A
    Atherosclerosis; 1976 Sep; 24(3):407-19. PubMed ID: 971343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.